2 recruiting, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Juvenile Myoclonic Epilepsy: new trials by email Literature Review of Juvenile Myoclonic Epilepsy trials Research Report on Juvenile Myoclonic Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy JZP926 capsule, Placebo - Juvenile Myoclonic Epilepsy | Phase 2 / Phase 3 | Recruiting | Jazz Pharmaceuticals | 260 | 2026-09-18 | 2026-10-06 |
| Flunarizine for Treatment Resistant Absence Epilepsy Flunarizine Hydrochloride - Childhood Absence Epilepsy, Juvenile Absence Epilepsy | Phase 2 | Terminated | University of British Columbia | 9 | 2019-09-20 | 2023-12-01 |
| Biology of Juvenile Myoclonic Epilepsy Blood draw, Existing samples - Juvenile Myoclonic Epilepsy | Recruiting | King's College London | 1000 | 2017-07-13 | 2025-09-05 |
Myoclonic Epilepsy, Juvenile (3) · Epilepsy (1) · Epilepsy, Absence (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Epilepsies, Myoclonic (3) · Epilepsy, Generalized (3) · Epileptic Syndromes (3) · Nervous System Diseases (3) · Epilepsy (2)
Blood Specimen Collection (1) · Flunarizine (1)
Jazz Pharmaceuticals (1) · King's College London (1) · University of British Columbia (1)
Canada (2) · United States (2) · Czechia (1) · Denmark (1) · Estonia (1) · France (1) · Italy (1) · Norway (1) · United Kingdom (1)
K Pal, MD PhD (1)